Atlas Trials

A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Clinical trial NCT04961567 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04961567
Sponsor
Biogen
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Lupus Erythematosus, Systemic
Start date
2021-07-16
Primary completion
2026-09-27
Enrollment
562

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.